Two Sigma Securities’s Editas Medicine EDIT Stock Holding History

Two Sigma Securities’s Portfolio EDIT Stock Details EDIT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$107K	Buy	33,138 +22,679	+217%	+$66.3K	0.01%	1288
2026 Q1	$25.8K	Sell	10,459 -33,411	-76%	-$70.7K	﹤0.01%	1338
2025 Q4	$89.9K	Buy	+43,870	New	+$127K	0.01%	993
2025 Q3	–	Sell	-11,402	Closed	-$25.1K	–	1548
2025 Q2	$25.1K	Buy	+11,402	New	+$18.7K	﹤0.01%	1176
2023 Q2	–	Sell	-11,626	Closed	-$84.3K	–	2908
2023 Q1	$84.3K	Buy	+11,626	New	+$103K	﹤0.01%	2226
2020 Q1	–	Sell	-32,149	Closed	-$952K	–	1593
2019 Q4	$952K	Buy	+32,149	New	+$803K	0.01%	1070

Other funds holding EDIT

TCM

TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

ACM

ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return

Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

PBA

Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

Two Sigma Securities's EDIT Position: Q2 2026 in Review

Two Sigma Securities increased its Editas Medicine (EDIT) stake by 217% in Q2 2026, buying an estimated $66.3K and bringing the position to 33,138 shares worth $107K. The position accounts for 0.01% of the portfolio, ranked #1288.

Two Sigma Securities first reported a position in EDIT in Q4 2019 and has held it in 6 quarters since. The position peaked at $952K in Q4 2019. 215 funds tracked by Wall St. Rank hold EDIT as of Q2 2026.

Two Sigma Securities held 33,138 shares of Editas Medicine worth $107K as of Q2 2026.
Two Sigma Securities bought 22,679 Editas Medicine shares in Q2 2026, an estimated $66.3K.
Editas Medicine made up 0.01% of Two Sigma Securities's portfolio in Q2 2026, its #1288 holding.
Two Sigma Securities first reported a position in Editas Medicine in Q4 2019 and has held it in 6 quarters since.
Two Sigma Securities's Editas Medicine position peaked at $952K in Q4 2019.
215 funds tracked by Wall St. Rank held Editas Medicine as of Q2 2026.

Based on Two Sigma Securities's 13F filing for Q2 2026, filed 14 Aug 2026.